CEO exercised or converted 55K DGX derivative securities | OQRO Insider trades- Derivative units · @ $95.795
Why it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 25, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 28, 2025
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001022079-25-000233
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerQUEST DIAGNOSTICS INC Reporting personJ. E. Davis RelationshipDirector, Officer Officer titleCEO and President SecurityNon-Qualifed Stock Option (right to buy) TableDerivative (Table II) Transaction dateNov 25, 2025 Acquired / disposedDisposed (D) Footnotes from the filing
- This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.
Around the same time
Congressional tradeHeld by the filer's joint per the disclosure. Disclosed 38 days after the transaction; reported as an official range, not an exact amount.
A board member of Quest Diagnostics sold $240K of Quest Diagnostics shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.